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There is abundant evidence from both in vivo (1-7) and in vitro (8-15) experiments 
that more than one cell  type contributes to the immune response of mice to sheep 
erythrocytes. Moreover, there seems to be agreement that the marrow contains direct 
precursors (1, 2, 4) of cells producing hemolysin directed against this antigen. Less clear 
are the roles of the cooperating cells, the number of different kinds involved, and their 
relative abundance in the various cell sources which have been shown to act synergis- 
tically with marrow; that is, thymus (1, 2), thoracic duct lymph (2), and spleen (5). 
Another source of cells known to interact with others during initiation of an immune 
response is the peritoneal cavity (16-20), which contains a mixture of cell types, al- 
though emphasis is usually placed on the macrophages. The results of experiments re- 
ported in this paper indicate that cells present in the marrow and in the peritoneal 
cavity can interact in irradiated mice to produce a  synergistic immune response to 
foreign erythrocyte antigens; and moreover, that a synergistic immune response still 
occurs if the mouse peritoneal cavity cells are replaced by those from rats or by an 
aqueous extract made by heating such cells. The activities of the marrow cells, the 
peritoneal cavity cells, and the extract of the peritoneal cavity cells are antigen de- 
pendent, in the sense that cells or extracts from animals previously immunized with 
the test antigen produce much stronger synergistic immune responses than do cells 
from unimmunized animals. Prior immunization  of the donor animals is often not re- 
quired if sheep erythrocytes are used, since most adult mice and rats are already im- 
mune, although the degree of immunity varies greatly from one group of animals to 
another. 
Materials and Methods 
Animals.--(CA)Fl(Balb/c >(A) mice were obtained from the Jackson Laboratory,  Bar 
Harbor,  Me., at about 6 wk of age and were held for 24 wk before use. Either all males or 
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all females were used in any given experiment. Young adult  Sprague-Dawley rats were ob- 
tained from a local source. 
Cells. Bone marrow cells were expressed from the femurs with cold medium 1 by means of a 
syringe and attached needle. Cells were dispersed by gentle pipetting, freed of large clumps by 
passage through 250 mesh stainless steel screen, washed by centrifugation at 650 g for 5 rain, 
and resuspended in medium. 
Peritoneal  cavity  cells were  obtained  from  mice  following  exsanguination  under  ether 
anesthesia. 2 ml of medium were injected into the peritoneal cavity; then the skin was peeled 
from the abdominal muscles and the fluid recovered by means of an 18 gauge needle on a 2 ml 
syringe. Care was taken not to damage the surrounding tissue. Any fluid grossly contaminated 
with erythrocytes or inflammatory exudate was discarded. Such care was necessary to prevent 
spontaneous clumping of the peritoneal cavity cells. Heparin was not used nor were the mice 
stimulated by previous intraperitoneal injections. Rat peritoneal cavity cells were obtained in 
a similar manner, the main differences being that 20 ml of medium were injected and that the 
peritoneal cavity was opened along the mld-line to facilitate recovery of the fluid. 
Thymus lobes were removed, care  being taken  to cut  away the fascial tags in  order to 
avoid contamination with the nearby lymph nodes, and  the tissue was disrupted  by gentle 
aspiration with a  1 ml syringe. The cell suspension was freed of clumps by passage through a 
250 mesh stainless steel screen. Cells were washed by centrifugation at  650 g for 5  min and 
then resuspended in medium. 
Sheep and burro erythrocytes (SRBC and BRBC) were collected in Alsever's solution and 
washed three times in medium. The same sheep or burro was used as donor for all experiments. 
All cell injections were via the tail vein. 
Cell Counling.--Cell  nuclei were counted in a Neubauer chamber after appropriate dilution 
in 1% acetic acid containing crystal violet. SRBC and BRBC were counted in a  Coulter elec- 
tronic counter (Coulter Electronics, Inc., Hialeah, Fla.). 
Irradiation.--Mice were prepared as cell recipients by exposure to 900 r from two opposing 
220  kvp  Picker X-ray tubes  (Picker  Corp.,  White Plains,  N.Y.)  160  cm  apart.  Each had 
inherent filtration of 0.25 mm Cu 4- 1.0 mm A1. They were operated at 200 kvp, 15 ma, and 
gave a  combined dose rate of 55  r/min to the mice in a lucite container midway between the 
machines.  2 
Hemolytic Plaque-Forming Cell (PFC) Assay.--The direct plaque method of Jerne, Nordin, 
and Henry (22)  was used. Spleens were removed from exsanguinated mice, minced in medium 
(1 ml per spleen) and passed several times through the orifice of a syringe to produce a single 
cell suspension which was then filtered through a 250 mesh screen. Various dilutions were mixed 
with 0.7%  agar  containing  1  mg/ml  DEAE-dextran in  Earle's  salts  and  either BRBC  or 
SRBC,  and  the mixture was  then  overlaid  on  a  bottom layer  of  1.4%  agar  in phosphate 
buffered saline (PBS) in petri dishes. After incubation at 37°C for 1 hr, 1.5 ml of a  1/10 dilu- 
tion of guinea pig serum in medium was added and the plates incubated 30 rain more at 37°C. 
The plates were then stained with benzidine and the plaques counted. 
Assay of Hemolysin and Hemagglutlnin Titers.--Twofold serial dilutions of the mouse sera 
were made in Levine's Tris buffer, starting with 0.6 ml of a  1:5 dilution. Hemagglutinin titers 
were determined by addition of one drop of 2% erythroeytes to each well and incubation for 
1 hr at  room temperature. The last well showing hemagglutination was recorded, and  then 
one drop of 1 : 10 dilution of guinea pig serum was added to each well. Hemolysin titers were 
read after 30 min at 37°C with constant agitation. 
1 In all cases, the medium was Eagle's modified by Vogt and Dulbecco (21). 
2 We  are  grateful  to  Dr.  Weigle and  Miss  McConahey  of Scripps  Clinic and  Research 
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Heated Supernatant.--The  once washed-peritoneal cavity cells in medium were heated at 
45°-48°C for 30 min, The cells were removed by centrifngation at  15,000 g for 10  min, the 
supernatant was retained, and the pellet was taken up in a volume to give the same cell con- 
centration  as  unheated  cells that  were  to  be injected.  Supernatants  were  correspondingly 
diluted. 
Antisera.--Mouse  anti-rat  spleen sera were prepared  by  injecting  a  homogenate  of rat 
spleen in Freund's adjuvant  intraperitoneally into  (CA)F1 mice and bleeding them out 20 
days later. Rat anti-mouse spleen sera were similarly prepared by injection of mouse spleen 
into two rats. Rabbit anti-mouse gammaglobulin was received from Dr. Paul Knopf who had 
prepared it by injection of the Fab fragments of purified mouse gammaglobulins. It was ab- 
sorbed with rat serum before use in these experiments. 
RESULTS 
Interaction  of Marrow  and  Peritoneal  Cavity Cells  to  Produce  a Synergistic 
Immune  Response.--Neither  marrow  cells  nor  peritoneal  cavity  cells  alone 
could restore, within a short time, the immune capacity of irradiated recipients; 
however, mixtures of these cells could do so. Results of experiments showing this 
effect are given in Table I. In these experiments, fixed numbers of marrow cells, 
peritoneal cavity cells,  and SRBC were given in a single injection. The spleens 
of the recipients were removed and assayed for plaque-forming cells (PFC)  10 
days later, since previous growth curve experiments had shown that at this time 
the synergistic immune response was well  developed and the immune system 
of the  irradiated recipient was  not yet capable of responding on its  own  to 
SRBC antigens. 
Preliminary studies  using  constant numbers  of  cells from one source  and 
increasing numbers of cells from the other led us to choose 2 )< 108 bone marrow 
cells and 1  X  106 peritoneal cavity cells as the optimal combination. Higher 
numbers of peritoneal cavity cells often inhibited the synergistic response with 
2 X  106 marrow cells or else gave too high a background response in the absence 
of marrow. The responses shown in Table I  are of the same magnitude as those 
reported by Mitchell and Miller  (4)  for injections of 106 thoracic duct cells 
alone or of 5 X  107 thymus cells with 107 bone marrow cells. 
Effect  of Antigen on Marrow Cells and Peritoneal  Cavity Cells  Transplanted 
into Irradiated Mice.--The number of anti-sheep hemolysin-producing cells in 
the spleens of normal mice begins to rise  above the background levels within 
24-36 hr after immunization with SRBC. However, there is a delay of approxi- 
mately 4  days before the synergistic immune response becomes detectable in 
heavily-irradiated mice injected with a suspension containing suitable numbers 
of marrow and peritoneal cavity cells. Similar delays are found if small numbers 
of spleen cells or mixtures of marrow and thymus cells are injected instead. If 
this delay is caused by a requirement for transplanted cells to reestablish the 
necessary anatomical relationships or to differentiate or multiply before taking 
part in  the initiation  of an immune  response, it might be possible to detect 
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the  marrow  and  peritoneal  cavity cells  separately,  with  an  appropriate  time 
interval between injections. Moreover,  by experiments of this general design it 
becomes possible to examine in greater detail the role of antigen in the initiation 
of the synergistic immune response. 
In one group of experiments, peritoneal  cavity cells and sheep  erythrocytes 
were  injected  together  into  irradiated  recipients.  Some  of  these  recipients 
received marrow cells at  the same time, while others were  given marrow  ceils 
after intervals of up to 4  days. Spleens were assayed for plaque-forming cells 5, 
7,  9,  11,  and 13  days  after  the initiM injection. There was no indication that 
the immune responses of those mice which had received peritoneal cavity cells 
TABLE I 
Interaction  of Bone Marrow and  Peritoneal  Ca~'ity Cells to Produce  an  Immune Response  to 
Sheep Erythrocytes in Irradiated  Mice 
Number of  cells/mouse 
Marrow  Peritoneal  SRBC 
Plaque-formlng cells/spleen* 
Experiment No. 
36  38  40+  + 
2 X  10  s  1 )< 10 's  2 X  10 ~  477  552  655  (48-1618) 
2 X  10 ~  None  2 )< 10  ~*  i08  72  8  (0-20) 
None  1 X  10  ~  2 X  10  s  43  80  28  (12-64) 
None  None  2 X  10  a  24  8  5  (0-8) 
* From pools of five or more spleens per group 10 days after transfer of cells and antigen 
into irradiated  recipients. Results  are  expressed  as  mean number of  plaques per  spleen. 
Plaque counts were made on 4-10 plates after suitable dilution. 
:~ In this experiment, spleens were assayed individually rather than as a pool.  Figures in 
brackets indicate range of values found within each group of five spleens. 
and SRBC before being given marrow cells were any different from the responses 
of  the  mice  which  had  been  given  both  types  of  cells  in  a  single injection. 
Problems with survival of irradiated mice in the absence of bone marrow made 
it difficult to study the effect of intervals greater than 4 days between injections 
when peritoneal cavity cells were given first. However,  when marrow cells were 
given first, there was no survival problem, and the interval between injections 
could be extended  to  10 days  without danger of a  spurious immune response 
from the regenerating immune system of the host animal. Table II summarizes 
the results of two such experiments. 
In one experiment, heavily-irradiated mice were  injected with either 2  X  106 isologous 
marrow cells or a mixture containing 2 X  10 6  marrow  cells and 2 X  l0 s SRBC. 8 days later 
these same mice were given either 1 X  106 peritoneal cavity cells, 2 X  108 SRBC, or a mixture 
containing both (lines 5-9, Tables II). At the same time, another group of mice were irradiated 
and injected with 2 X  106 marrow cells, 2 X  l0 s SRBC, and 1 X  106 peritoneal cavity cells 
mixed in the various combinations  indicated (lines 1-4, Table II). The same peritoneal cavity 
cell suspension was used for both groups of mice. Two marrow cell suspensions,  each a pool of 
cells from 20 femurs, were used. 9 days later, spleens from each group were pooled and assayed 
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The  first 4  lines of Table II  show results very similar to  those presented  in 
Table I;  again it is apparent  that both marrow  and peritoneal cavity cells are 
required for the synergistic immune  response when cells from both sources are 
given as a  single injection. The next 5  lines summarize that part  of the experi- 
ment in which the marrow  and peritoneal cavity cell injections were separated 
by  an interval  of  8  days.  Several  points  should  be noted.  First,  marrow  cells 
injected without  SRBC  and left for 8  days in the irradiated  recipients appear 
TABLE  II 
Interaction of SRBC  with  Marrow and  Peritoneal Cavity  Cells 
1st Injection  2rid  Injection  Average 
Days  Number* of  number 
between  Ist  1 X  10 s  I  X  10 6  spleens  plaque- 
and 2nd  2  X  10 6  2 X  10  s  Peritoneal  Peritoneal  2  X  I0  8  xormmg 
injections  Marrow cells  SRBC  cavity cells  cavity cells  SRBC  assayed  cells per 
spleen 
0  +  +  +  -  -  8  797 
0  +  +  -  -  -  8  28 
0  -  +  +  -  -  4  22 
0  -  +  -  -  -  8  6 
8  +  +  -  +  +  5  1755 
8  +  -  -  +  +  7  285 
8  +  +  --  +  --  6  62 
8  +  +  --  --  +  5  160 
8  +  --  --  --  +  8  58 
0  +  +~  +  --  --  10  34 
2  +  +  --  +  +  10  33 
4  +  +  --  +  +  10  100 
6  +  +  --  +  +  10  325 
8  +  +  --  +  +  10  3325 
* The first nine groups belong to one experiment; spleens were pooled and assayed 9 days 
after the peritoneal cavity cell injection. The last five groups were assayed 4 days after the 
second injection. 
~; The mice of this one group were given 4  X  10  8 SRBC, so that the total antigen dose is 
equal for all five groups of this experiment. 
to  be  no  more  effective  in  producing  a  synergistic  immune  response  with 
peritoneal  cavity cells than  are marrow  cells injected at  the same  time as  the 
peritoneal  cavity  cells  and  SRBC.  Second,  the  strongest  immune  response 
occurs when SRBC  are present in both  the marrow  and the peritoneal  cavity 
cell  injections.  However,  this  effect  of  two  doses  of  antigen  is  not  simply  a 
secondary response by the irradiated mice or by the transplanted  marrow  cells, 
since  a  second  injection  of  SRBC  in  the  absence  of  peritoneal  cavity  cells  is 
relatively ineffective (line 8,  Table I1).  Nor is the effect caused by an increase 
in total  antigen dose,  since in other experiments we have shown that a  dose of 358  ANTIGEN-SPECIFIC SYNERGISM IN  MICE 
1 X  l0  s SRBC given with both marrow and peritoneal cavity cell injections is 
far more effective than is a single dose of 2  X  10  8 SRBC given with either the 
marrow or the peritoneal cavity cell injection but not with both.  It  appears 
then that  the injection of  SRBC into irradiated mice bearing marrow grafts 
does  not in itself lead  to  a  detectable  immune response,  but it does  have  a 
definite enhancing effect  on the  ability of  such mice to  respond to  a  second 
injection containing both SRBC and peritoneal cavity cells. The other experi- 
ment of Table II  (lines 10-14)  shows how this enhancing effect varies as the 
time interval between marrow and peritoneal cavity cell injections is varied. 
Irradiated  recipients were given 2 X  10 ~ marrow cells and 2 X  l0  s SRBC; after intervals 
of either 0, 2, 4, 6, or 8 days, 1 X  106 peritoneal cavity cells and 2 X  108 more SRBC were 
injected. The times chosen for irradiation and marrow cell injection were such that all mice 
could be given peritoneal cavity cells on the same day and from the same pool; each of the 
five different marrow cell suspensions was made from the pooled cells of 20 femurs. Spleens 
were assayed for plaque-forming cells 4 days after the second injection, since we had found 
that when irradiated  mice are given marrow and SRBC a few days before they receive a 
second injection containing peritoneal cavity cells and more SRBC, the growth curves of the 
synergistic immune response do not show the initial delay of 4 days found when both cell 
types are injected simultaneously but instead are very similar to those of intact mice. 
As the data of the last 5 lines of Table II indicate, there is very little immune 
response 4  days  after  the  simultaneous injection of  marrow  cells,  peritoneal 
cavity cells and SRBC,  but there is a  progressively stronger response as  the 
interval between marrow  and peritoneal cavity cell  injections increases.  We 
could extend this interval up to about 10 days without detectable response by 
the irradiated recipient's regenerating immune system. 
The experiment summarized in Table III is one of several designed to examine 
the specificity of the part played by antigen during initiation of the synergistic 
immune response. 
Irradiated mice were divided into three equal groups; all received 2 X  106 marrow cells, 
but some were given in addition either 2 X  108 SRBC or 2 X  108 BRBC. 8 days later the 
mice were injected again; half of the mice in each group were given 1 X  10 ~  peritoneal cavity 
cells and 2 X 108 SRBC, while the other half were given the same number of peritoneal cavity 
cells and BRBC.  10 spleens from each of the six subgroups were assayed for plaque-forming 
cells, 3, 4, 5, 7, and 9 days later, on both SRBC and BRBC. 
The data of Table III show that by far the best response to SRBC occurred 
when SRBC were given with both the marrow and the peritoneal cavity cell 
injections, and  that  under these  conditions the  peak  of  the  response  was  4 
days  after  the  last  injection.  Omitting  the  SRBC  from  either  injection or 
substituting BRBC  for  SRBC  produced  a  much  weaker  response.  We  have 
already  shown  (Table II)  that  irradiated  recipients given marrow  cells  and 
SRBC  are  "primed" so that the later injection of peritoneal cavity cells and 
more SRBC "triggers" a rapid and strong immune response. The data of Table J.  C.  KENNEDY,  P.  E.  TREADWELL,  AND  E.  S.  LENNOX  359 
III confirm this result and indicate that the effect of the SRBC during both 
"priming" and "triggering" is antigen-specific. 
The very weak response to BRBC under conditions which produced a strong 
response to SRBC was of great interest. We show below that if the marrow and 
peritoneal cavity cell  donors  are  preimmunized with  BRBC,  the  synergistic 
immune response to BRBC can be as strong as that to SRBC. 
TABLE  III 
Specificity of Effect of Antigen Given with Marrow Cells or Peritoneal Cavity Cells  from 
Nonimmunized Donors 
Treatment*  Day of plaque assay:~ 
Day 0  Day 8 
2 X  10~  t  X  10  6 
Bone marrow  Peritoneal 
cells, plus  cavity cells, plus 
Assayed  on  It  12  14  15  17 
SP.BC  SRBC  SRBC  3930  10,250  2100  1130  2920 
BRBC  34  6  8  10  6 
SP,  BC  BRBC  SRBC  159  64  320  276  89 
BRBC  12  13  66  16  88 
BRBC  BRRC  SRBC  58  51  34  29  53 
BRBC  11  31  61  106  14 
BRBC  SRBC  SRBC  7  52  889  920  730 
BP.BC  3  12  8  6  8 
None  SRBC  SRBC  24  180  196  938  780 
BRBC  4  19  10  5  4 
None  BRBC  SRBC  10  54  26  18  34 
BRBC  4  1  8  4  22 
* Mice which had been irradiated with 900 r were injected with bone marrow cells plus 
2 X  108 sheep or burro erythrocytes as indicated; 8 days later they received peritoneal cavity 
cells and 2 X  108 erythrocytes as indicated. 
:~ Average number of plaque-forming cells per spleen from pools of 10 spleens per group. 
Effect  of Prior Immunization  of Cell Donors  on  the Synergistic  Immune Re- 
sponse in  Recipient Mice.--We had been concerned about wide variations in 
response from one experiment to another when SRBC were used as the antigen; 
in some experiments it was not possible to demonstrate any synergism between 
marrow and peritoneal cavity cells. The clue that this variability in response 
might be caused by variability in the state of immunization of the donor mice 
to antigen cross-reactive with SRBC came with the observation that deliberate 
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the subsequent synergistic response with normal marrow cells.  The possibility 
was raised that cells from mice which were not immune to any SRBC antigens 
would be incapable of responding at all; what we had considered to be a  pri- 
mary synergistic immune response might be dependent  upon  a previous acci- 
dental immunization with cross-reacting antigens. The use of BRBC as antigen 
provided a  way to test this possibility experimentally. The very low numbers 
of plaques found when spleens of unimmunized mice were assayed on BRBC 
suggested  that  accidental  immunization  to  this  particular  antigen  was  very 
uncommon,  and,  as  shown  in  Table  III,  the  use  of  marrow  and  peritoneal 
cavity cells from unimmunized mice produces a very weak synergistic response 
which provides a good base line for studying the effect of deliberate immuniza- 
tion with BRBC.  Preimmunization of the donors of either the marrow or the 
peritoneal  cavity cells (but not both) led to similar weak responses. However, 
as Table IV shows, there is strong synergism when both types of cells are ob- 
tained from preimmunized donors. 
In these experiments, the marrow donors and the peritoneal cavity cell donors were im- 
munized 21 and 30 days, respectively, prior to use as cell sources. Heavily irradiated recipient 
mice were injected with 2  X  106 marrow cells mixed with 2  X  108 BRBC; 8 days later, peri- 
toneal cavity  cells from either isologous mice  or  Sprague-I)aw]ey rats  were injected  along 
with 2  X  108 BRBC; 4 days later, 8-10 spleens from each group were pooled and assayed. 
The results shown in Table IV indicate that a strong synergistic response to 
BRBC is possible if both types of cells are obtained from preimmunized donors. 
The ability of rat peritoneal cavity cells to replace mouse cells in the syner- 
gistic immune response made it possible to examine the origin of the plaque- 
forming cells and of the serum hemolysin.  In vitro incubation  of the plaque- 
forming  cells  with  rat  anti(CA)F1  spleen  antiserum  and  complement  was 
effective in reducing the number of plaques while incubation with mouse anti-rat 
spleen  antiserum  was  not.  Details  of  these  experiments  are  not  given  here, 
since the later demonstration that an aqueous extract of peritoneal cavity cells 
could replace such cells in the synergistic immune response with marrow makes 
it  quite  evident  that  the precursors of the  plaque-forming cells were derived 
from  the  marrow  cell  suspension.  In  other  experiments,  we  found  that  the 
hemolysin  titer  of  serum  from  mice  showing  a  strong  synergistic  immune 
response was reduced  by incubation  with rabbit anti-mouse immnnoglobulin 
antiserum which was still capable of binding 19S mouse hemolysin  after being 
absorbed with normal rat serum. 
Nature of the Interaction  between Marrow and Peritoneal Cavity Cells.--The 
observation that cells from different species can interact to produce a synergistic 
immune response made it seem likely that a soluble factor was involved rather 
than direct cell  contact. The following experiment was designed to distinguish 
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Recipient mice were prepared by irradiation  and the injection of a mixture of 2 X  l0  s 
BRBC and 2 X  106 isologous marrow cells from mice immunized with  1 X  107  BRBC  19 
days previously; 8 days later, the mice were given 2 X  10 s BRBC and either thymus cells, 
untreated peritoneal cavity cells, heated  (45°C for 30 rain) peritoneal cavity cells, or super- 
natant from these heated cells. Both thymus and peritoneal cavity cells were obtained from 
mice immunized with BRBC 8 days before use, or from rats immunized 27 days previously. 
The results of assays 4 days after the last injection are summarized in Table V. 
It can be seen that heated peritoneal cavity cells and the supernatant from 
these  cells  are  effective in increasing the  PFC  and hemolysin response,  and 
that the response obtained is about the same as that obtained from 50 times 
more thymus cells. There is one discrepancy in the Table; the PFC response of 
TABLE  IV 
Effect of Immune Status of Donors of Marrow and Peritoneal Cavity Cells on Immune Respon 
to Burro RBC 
1st Injection* 
Number and source of marrow cells 
2nd Injection* 
Number and source of 
peritoneal  cavity cells 
Average number 
plaque-forming 
cells per spleeM: 
2 X 106, normal mice  5 X 105, immune mice§  18 
None  5 X 105, immune mice§  30 
2 X 106, immune micell  None  110 
2 X 106, immune mice]l  5 X 105, immune mice§  865 
None  2.5 X 105, immune rats¶  88 
2 X  10  6, immune micell  2.5 X 10 5, immune rats¶  1840 
2 X 10  6, immune micell  2.5 X 10  4, immune rats¶  1140 
* All irradiated mice received 2 X 108 BRBC in both 1st and 2nd injections, with an 8 day 
interval between these injections. 
:~ Pools of eight or more spleens assayed 4 days after the 2nd injection. 
§ Cells from mice injected intravenously 30 days previously with 2 M 10  s BRBC. 
[l Cells from mice injected intravenously 21 days previously with 2 X  10  s BRBC. 
¶ Cells from rats injected intraperitoneally 30 days previously with 2 X  108 BRBC. 
immune marrow cells alone is very much higher than usual. (See Table II and 
Table IV for usual values). This may be due to an abnormally high response 
by one or more of the recipient mice whose spleens were pooled for assay. Other 
groups showed the usual levels of response. 
The question arises whether the active factor in the supernatant from heated 
peritoneal cavity cell suspensions was derived from the cells or from the peri- 
toneal fluid. That it comes from the cells was shown by experiments in which 
repeated washing of the ceils failed to remove their ability to act synergistically 
with marrow cells in irradiated mice. Moreover, the peritoneal fluid itself was 
not active. Whether thymus ceils are more effective when taken from immune 
donors and whether a soluble thymus factor is involved has not yet been tested. 
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TABLE  V 
Effect of Heated Peritoneal  Cavity Cells and Extracts from Immunized Donors 
1st  Log.~  Number 
Injection,*  2nd Injection,* as indicated  Plaque-forming  hemolysin  mice  per 
2 X 10~  cells per spIeen  titre  group 
marrow cells 
+  None  1140  2.98  7 
+  5  X  105 mouse peritoneal  470  2.70  7 
--  5  X  105 mouse peritoneal  40  ND  4 
+  1 X  106 heated mouse peritoneal  3800  4.13  7 
+  Supernatant from I  X  106 heated cells above  2525  4.32  7 
+  5  X  105 rat peritoneal  1010  5.17  7 
--  5  X  105 rat peritoneal  20  ND  1 
+  1 X  106 heated rat peritoneal  3420  5.32  7 
+  Supernatant from 1 X  106 heated cells above  5080  5.98  6 
+  50  X  106 mouse thymus  3800  6.48  6 
+  50  X  l0 s rat thymus  2620  5.82  6 
* All mice were given 2  X  l0  s burro RBC  at each injection.  The bone marrow cells  were 
from mice immunized 19 days previously with 1 X  l0  T BRBC i.v. The mouse cells used in the 
2nd injection were from peritoneal cavity or thymus of mice immunized 8 days previously; 
the rat cell  donors were immunized 27  days previously. 
TABLE  VI 
Antigen-Specific  Effect of Supernatant from Heated Peritoneal Ca~,ity Cells 
Second injection* 
Heated rat peritoneal cavity cell supernatant,~ in cell  Average number§ 
equivalents injected per recipient  plaque-forming 
cells/spleen 
From SRBC-  From saline-lnjected rats  From BRBC-immune rats  immune rats 
5 X  105  --  --  420 
--  5  X  105  --  90 
--  --  5>(105  60 
2.5X  105  --  --  315 
--  2.5X  105  --  45 
--  --  2.5X  105  82 
--  --  --  60 
* For the first injection, all mice were given 2 X  l0 s BRBC and 2 X  106 isologous marrow 
cells from donors immunized 20 days prior to use. For the second injection, all mice were given 
2  X  l0  s BRBC  and either heated  peritoneal cavity cell  supernatant from one of the three 
groups of rat donors, or Eagle's medium as a  control. 
Peritoneal cavity cells which had been heated at 45°C for 30 min and centrifuged to pro- 
vide supernatant were from Sprague-Dawley rats immunized with BRBC,  SRBC,  or sMine 
17 days prior to use. The cells of three rats were pooled to make each suspension. 
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Antigen-Specific  Effect of the Factor Extracted from Immune Peritoneal Cavity 
Cells.--Intact peritoneal cavity ceils have an effect on the synergistic immune 
response which can be described as antigen-specific in the sense that the cells 
of donor  animals  immune  to  one particular  antigen  do  not  trigger  a  strong 
synergistic immune response to other antigens.  (See  Table III). Supernatants 
from heated peritoneal  cavity cells were examined to see whether or not they 
also have this property. 
Mice were irradiated and given a  mixture of 2  X  l0 s BRBC and 2  X  106 marrow cells 
from isologous donors immunized with BRBC 20 days previously. After 8 days, the recipient 
mice were given 2  X  l0 g BRBC and aliquots of supernatant from heated peritoneal cavity 
cells;  these cells were  obtained from groups  of  three  Sprague-Dawley  rats  injected intra- 
peritoneally 17 days previously with either (a) 3 ml of 10% BRBC,  (b) 3 ml of 10% SRBC, 
or (c) 3 ml of saline. Recipient spleens were pooled and assayed on BRBC 4 days later. The 
results are summarized in Table VI. 
It can be seen that, for two different concentrations of supernatant injected, 
the mice which were given the supernatant of peritoneal cavity cells from rats 
immunized with BRBC  produced  an immune response against BRBC,  while 
the other mice had only background numbers of plaques. It would appear that 
the active factor in the supernatant is antigen-specific. However, the factor does 
not appear to be immunogenic, since in other experiments it was shown that, 
in the absence of BRBC, the extracts cannot induce an immune response either 
in  irradiated  mice  carrying  BRBC-imnmne  marrow  or  in  intact  adult  mice 
primed several months previously with BRBC. 
DISCUSSION 
The  experimental  results  outlined  above  lead to three major  conclusions: 
First, cells obtained  from bone marrow  and cells obtained from the peritoneal 
cavity can interact in lethally irradiated mice to produce  a synergistic immune 
response to foreign erythrocytes.  (Tables I-IV). Second,  the  effectiveness of 
the cells taking part in the synergistic immune response is antigen-specific in 
the  sense  that  the  response is  greatest  if both  cell  types  are  obtained  from 
specifically immune donors.  (Tables III and IV,  and other data presented in 
text).  Third,  a  material  extractable by gently heating peritoneal  cavity cells 
from immunized  animals  is  capable  of  substituting  for  the  intact  cells  in  a 
synergistic  immune  response  with  marrow  cells.  (Tables  V  and  VI).  This 
material is antigen-specific in the same sense as are the cells from which it is 
derived (Table VI). 
Synergistic interactions of marrow have been reported previously with ceils 
from thymus (1,  2,  14),  thoracic duct lymph (2),  and spleen (5). It will be of 
great interest  to learn  whether  or not  the  mechanism of  action  and  the  cell 364  ANTIGEN-SPECIFIC  SYNERGISI~  IN  MICE 
types involved are the same in each case. Cells capable of producing a synergistic 
immune response with marrow and sharing the density characteristics of thymus 
cells have been isolated from thoracic duct lymph (J. S. Haskill, G. F.  Mitchell, 
and J.  F.  A.  P.  Miller,  personal  communication),  but up to the present such 
cells have not been reported from the peritoneal cavity. The relative proportion 
of  the  active  cells  may be  quite  different  in  cell  suspensions  obtained  from 
different  sources;  although  comparable numbers  of  cells  from the  peritoneal 
cavity and thoracic duct lymph produce quite comparable levels of synergistic 
immune response with marrow ceils,  50 times that number of thymus cells are 
required  to produce a  similar response (4).  It is possible that the active cells 
of thymus form a very minor part of the total thymus population. 
Cells  from specifically immune  donors  produce  a  much  better  synergistic 
response than do cells from untreated  animals. This was most apparent  when 
burro erythrocytes were used (Tables III and IV), since there is little "natural" 
immunity to this antigen, but the effect of preimmunization of donors was also 
clear when sheep erythrocytes were used. However, the great variability in the 
synergistic immune response to sheep erythrocytes when  cells from untreated 
donors  were  used  strongly  suggested  that  there  was  great  variation  in the 
immune status of these donor mice. A similar conclusion was reached by Nossal 
et al. (23). In view of this variability, it seems unfortunate that so many studies 
of the  "primary" immune response use  sheep erythrocytes as antigen;  burro 
erythrocytes would seem preferable. 
The active factor obtained from heated peritoneal cavity cells increases with 
prior immunization of the donors,  and is antigen-specific in its effect on irra- 
diated mice bearing marrow grafts.  Since it is antigen-specific in its effect, it 
can not be acting merely as an adjuvant or as a nonspecific growth factor (24). 
Processed  antigen  (25,  26),  specific antibody  (27),  or  specific RNA  (28,  29) 
would seem to be possibilities, not all equally likely. Since neither the peritoneal 
cavity cells nor the supernatant  obtained from them appears to be capable of 
triggering  an  immune  response  in  the  absence  of  antigen,  even  in  primed 
animals, the active factor is probably not some form of processed antigen. The 
reported effects of specific RNA from immunized animals include  the appear- 
ance of donor antigens on the resulting antibody (28,  29). Although the hemol- 
ysin produced in irradiated mice given mouse marrow and rat peritoneal cavity 
cells had detectable mouse antigens, we were unable to detect any rat antigens 
by  means  of mouse  anti-rat  gammaglobulin  antiserum.  G6nsequently,  some 
form of antibody is at present the most likely agent. Attempts to isolate and 
characterize the active factor are now in progress. 
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potential of their marrow cells for synergistic activity following transplantation 
may be related to the mechanism by which the presence of antigen in irradiated 
mice bearing  marrow  grafts  "primes"  the  cells  so that  the  later  injection  of 
more antigen and peritoneal  cavity cells or extract triggers a strong and rapid 
response  (Table II). Either antigen-induced differentiation  or antigen-induced 
proliferation  may be  involved.  The possible  involvement of the  regenerating 
thymus  or  reticuloendothelial  system  of  the  irradiated  hosts  remains  to  be 
investigated. 
SUMMARY 
A  synergistic immune  response  to foreign erythrocytes  may be  induced  in 
heavily irradiated mice injected with a mixture of isologous cells obtained from 
marrow and from the peritoneal cavity. Under appropriate  conditions, homol- 
ogous  or  heterologous  peritoneal  cavity  cells,  heat-killed  cells,  or  ce]lfree 
extracts made from such cells are also effective. The activity of the peritoneal 
cavity cells  or extracts  is  antigen-specific,  in  the  sense  that  cells  or extracts 
obtained  from animals  previously  immunized  with  the  test  antigen produce 
much stronger synergistic effects than  do cells from animals  immunized with 
some  other  antigen;  however,  the  peritoneal  cavity cells  or extracts  are  not 
immunogenic when tested in primed animals.  The marrow cells, demonstrated 
to  contain  precursors  of  the  antibody-forming  cells  produced  during  this 
synergistic immune response, also show a form of antigen-specificity. 
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